GO:0048168 regulation of neuronal synaptic plasticity: Regulatory Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048168 (regulation of neuronal synaptic plasticity) is a biological process that modulates the ability of synapses to change their strength, number, or function in response to experience.
• Synaptic plasticity regulation involves coordinated excitatory and inhibitory changes, structural remodeling of dendritic spines, and astrocyte-microglia interactions.
• Key molecular mechanisms include S-palmitoylation of synaptic proteins, alternative splicing of neuronal genes, and epigenetic control of autophagy.
• Dysregulation of synaptic plasticity is linked to neurodevelopmental disorders, neurodegeneration, and psychiatric conditions.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal testing of plasticity-regulating genes.
• Advanced methods such as Ribo-seq, RNA-seq, proteomics, and live imaging are essential for dissecting plasticity regulatory networks.
Description
Regulation of neuronal synaptic plasticity (GO:0048168) is a fundamental biological process that governs how synapses modify their strength, structure, and number in response to neural activity or environmental changes. This process is essential for learning, memory, and adaptive behavior, and its disruption contributes to numerous neurological and psychiatric disorders. Understanding the regulatory mechanisms of synaptic plasticity is therefore a central goal in neuroscience research. Recent studies have revealed that synaptic plasticity is not solely a neuron-intrinsic property but is dynamically regulated by diverse cellular and molecular players, including glial cells, epigenetic modifiers, and post-translational modifications. For example, microglia have been shown to regulate neuronal activity via structural remodeling of astrocytes, which in turn influences synaptic plasticity. Similarly, inhibitory synaptic plasticity plays a critical role in shaping circuit organization and function. These findings highlight the complexity of plasticity regulation and the need for precise experimental models to dissect causal relationships. This article provides a comprehensive overview of GO:0048168, covering its definition, key genes, regulatory mechanisms, disease relevance, and state-of-the-art research methods, with a focus on how CRISPR-based approaches can accelerate discovery in this field.
regulation of neuronal synaptic plasticity At A Glance
| GO ID | GO:0048168 |
|---|---|
| GO term | regulation of neuronal synaptic plasticity |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the ability of synapses to change strength, number, or function in response to experience. |
| Key cellular players | Neurons, astrocytes, microglia, and their interactions. |
| Molecular mechanisms | S-palmitoylation, alternative splicing, epigenetic regulation, and post-synaptic signaling. |
| Disease relevance | Neurodevelopmental disorders, neurodegeneration, and psychiatric conditions. |
| Research methods | CRISPR screens, Ribo-seq, RNA-seq, proteomics, and imaging. |
What Is GO:0048168?
According to the Gene Ontology (QuickGO), regulation of neuronal synaptic plasticity (GO:0048168) is defined as a process that modulates neuronal synaptic plasticity, the ability of neuronal synapses to change as circumstances require. This modulation can alter synaptic function, such as increasing or decreasing sensitivity, or it can change the actual number of synapses. In other words, it encompasses all molecular and cellular events that control the efficacy, stability, and structural remodeling of synaptic connections in the nervous system.
Why Is regulation of neuronal synaptic plasticity Important in Cell Biology?
Regulation of neuronal synaptic plasticity is critically important because it underlies the brain's capacity for learning, memory, and adaptation, and its dysfunction is a common feature of many neurological and psychiatric disorders. Understanding how this process is regulated at the molecular, cellular, and circuit levels can reveal therapeutic targets and biomarkers for conditions such as Alzheimer's disease, autism spectrum disorders, and depression. Moreover, synaptic plasticity regulation is not limited to neurons; glial cells such as astrocytes and microglia actively participate in shaping synaptic changes, offering new avenues for intervention.
• Underlies learning and memory formation by enabling experience-dependent synaptic changes.
• Dysregulation is implicated in neurodevelopmental disorders such as autism and intellectual disability.
• Contributes to neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.
• Involved in psychiatric conditions such as depression, schizophrenia, and addiction.
• Glial cells (astrocytes, microglia) actively regulate synaptic plasticity, expanding the scope of therapeutic targets.
• Post-translational modifications like S-palmitoylation dynamically control synaptic protein function.
• Alternative splicing generates diverse protein isoforms that fine-tune synaptic properties.
• Epigenetic mechanisms, including autophagy regulation, link metabolic and inflammatory states to synaptic plasticity.
• Inhibitory synaptic plasticity is essential for maintaining excitation-inhibition balance in neural circuits.
• Spatial coordination of excitatory and inhibitory plasticity at dendritic synapses is critical for information processing.
What Happens During regulation of neuronal synaptic plasticity?
Activity-dependent modulation of synaptic strength
In simple terms: When neurons are active, they can strengthen or weaken their connections with other neurons.
Regulation of neuronal synaptic plasticity begins with the detection of neural activity patterns that trigger intracellular signaling cascades. Excitatory synapses can undergo long-term potentiation (LTP) or long-term depression (LTD), while inhibitory synapses can also change their efficacy. These changes involve alterations in neurotransmitter release, receptor trafficking, and post-synaptic signaling. For instance, coordinated excitatory and inhibitory plasticity at dendritic synapses is spatially regulated to maintain circuit stability. Inhibitory synaptic plasticity is crucial for shaping circuit organization and function, and its dysregulation can lead to network imbalances.
Structural remodeling of synapses and dendritic spines
In simple terms: Synapses can physically change their shape and number, which affects how well neurons communicate.
Synaptic plasticity often involves structural changes, such as the growth or retraction of dendritic spines and the remodeling of synaptic contacts. Microglia have been shown to regulate neuronal activity via structural remodeling of astrocytes, which in turn influences synaptic plasticity. Astrocytes instruct hippocampal synaptic plasticity through neuronal activity-dependent regulatory mechanisms. These structural changes are driven by cytoskeletal dynamics and cell adhesion molecules, and they require coordinated signaling between neurons and glia.
Molecular regulation by post-translational modifications and splicing
In simple terms: Chemical tags and different versions of proteins can change how synapses work.
S-Palmitoylation, a reversible lipid modification, dynamically regulates the localization and function of synaptic proteins, thereby influencing neuronal plasticity in both normal and pathological brains. Alternative splicing of neuronal genes generates multiple protein isoforms that can have distinct functions in synaptic transmission and plasticity. These molecular mechanisms provide a layer of regulation that allows synapses to rapidly adapt to changing conditions.
Epigenetic and glial control of plasticity
In simple terms: Long-lasting changes in gene activity and support cells can control how plastic synapses are.
Epigenetic mechanisms, including DNA methylation and histone modifications, regulate the expression of genes involved in synaptic plasticity. Autophagy, a cellular degradation process, is epigenetically regulated in neuroinflammation and impacts synaptic plasticity. Astrocytes and microglia release signaling molecules that modulate synaptic plasticity, and their activity-dependent interactions with neurons are essential for proper circuit function. RGS14 is a post-synaptic signaling regulator that controls spine plasticity in the brain.
Key Genes Involved in GO:0048168 regulation of neuronal synaptic plasticity
The following genes and proteins are key players in the regulation of neuronal synaptic plasticity, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RGS14 | Regulates post-synaptic signaling and spine plasticity | Potential target for modulating synaptic strength in cognitive disorders |
| ARC | Activity-regulated cytoskeleton-associated protein involved in synaptic plasticity | Marker of recent synaptic activity and plasticity |
| BDNF | Neurotrophin that promotes synaptic plasticity and neuronal survival | Implicated in depression and memory disorders |
| GRIA1 | AMPA receptor subunit mediating excitatory synaptic transmission | Key for excitatory plasticity and receptor trafficking |
| GABRA1 | GABA-A receptor subunit mediating inhibitory synaptic transmission | Target for inhibitory plasticity and epilepsy research |
| DLG4 (PSD-95) | Scaffolding protein at post-synaptic densities | Central to organizing synaptic signaling complexes |
| SNAP25 | SNARE protein involved in neurotransmitter release | Subject to S-palmitoylation and regulates vesicle fusion |
| GRIN2B | NMDA receptor subunit critical for LTP and LTD | Genetic variants linked to neurodevelopmental disorders |
| CAMK2A | Calcium/calmodulin-dependent kinase II, key for LTP | Major regulator of synaptic strength and memory |
| MAPT (Tau) | Microtubule-associated protein involved in cytoskeletal stability | Hyperphosphorylation linked to neurodegeneration |
| APOE | Lipid transport protein with roles in synaptic maintenance | Risk factor for Alzheimer's disease |
| FMR1 | RNA-binding protein regulating synaptic protein synthesis | Loss causes fragile X syndrome and plasticity deficits |
| MECP2 | Methyl-CpG-binding protein regulating gene expression | Mutations cause Rett syndrome and synaptic dysfunction |
| SHANK3 | Scaffolding protein at post-synaptic densities | Linked to autism spectrum disorders |
| GRM5 | Metabotropic glutamate receptor modulating synaptic plasticity | Target for psychiatric and neurological disorders |
| ATP6V1A | V-ATPase subunit involved in synaptic vesicle acidification | Mutations linked to neurodevelopmental disorders |
| NEFL | Neurofilament light chain, structural component of axons | Biomarker for neurodegeneration |
How Is regulation of neuronal synaptic plasticity Regulated?
Regulation of neuronal synaptic plasticity is itself tightly regulated by multiple signaling pathways and cellular processes. For example, RGS14 regulates post-synaptic signaling and spine plasticity, acting as a key modulator of synaptic strength. S-Palmitoylation dynamically controls the localization and function of synaptic proteins, thereby regulating plasticity. Alternative splicing of neuronal genes generates protein isoforms that can either promote or inhibit plasticity. Epigenetic mechanisms, including the regulation of autophagy, link neuroinflammatory states to synaptic plasticity. Additionally, astrocytes and microglia provide activity-dependent regulatory signals that modulate synaptic plasticity. These layers of regulation ensure that synaptic changes are appropriately timed and targeted.
regulation of neuronal synaptic plasticity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SHANK3 | Autism spectrum disorder, synaptic dysfunction | Knockout mouse or iPSC-derived neurons |
| FMR1 | Fragile X syndrome, intellectual disability | Knockout mouse, CRISPR KO in cell lines |
| MAPT | Alzheimer's disease, tauopathy | Knock-in mouse expressing mutant tau |
| MECP2 | Rett syndrome, neurodevelopmental disorder | Knockout mouse, conditional KO |
| GRIN2B | Neurodevelopmental disorders, epilepsy | Point mutation knock-in mouse |
Neurodevelopmental disorders
Disruptions in the regulation of neuronal synaptic plasticity are strongly associated with neurodevelopmental disorders such as autism spectrum disorders and intellectual disability. Mutations in genes encoding synaptic scaffolding proteins (e.g., SHANK3) or RNA-binding proteins (e.g., FMR1) lead to altered plasticity and cognitive deficits. Epigenetic dysregulation, including abnormal autophagy, has been implicated in neuroinflammation and synaptic dysfunction. Understanding these mechanisms is essential for developing targeted therapies.
Neurodegenerative diseases
Synaptic plasticity deficits are early features of neurodegenerative diseases like Alzheimer's disease. Proteins such as Tau and APOE are involved in synaptic maintenance, and their dysfunction contributes to synaptic loss and cognitive decline. S-Palmitoylation defects have also been observed in pathological brains, linking lipid modification to neurodegeneration. Research into plasticity regulation may reveal new biomarkers and therapeutic targets.
Psychiatric and circuit disorders
Alterations in inhibitory synaptic plasticity can disrupt excitation-inhibition balance, contributing to epilepsy, schizophrenia, and mood disorders. RGS14, a regulator of post-synaptic signaling, has been studied for its role in modulating spine plasticity and may be relevant to psychiatric conditions. Spatial coordination of excitatory and inhibitory plasticity at dendritic synapses is critical for normal circuit function, and its disruption can lead to network instability.
From regulation of neuronal synaptic plasticity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of gene X impair synaptic plasticity? | CRISPR knockout in primary neurons or iPSC-derived neurons |
| Does a specific point mutation in gene Y alter plasticity? | CRISPR point mutation knock-in in cell lines or mice |
| Does overexpression of gene Z enhance plasticity? | CRISPR-mediated overexpression (e.g., CRISPRa) in neurons |
| How does a tagged version of protein W localize during plasticity? | Knock-in of fluorescent or epitope tag |
| Which genes regulate plasticity in a genome-wide manner? | CRISPR library screening in neuronal cultures |
| What are the transcriptomic changes during plasticity? | RNA-seq after CRISPR perturbation |
How to Study the regulation of neuronal synaptic plasticity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify transcriptional programs in plasticity |
| Ribo-seq | Translated mRNAs | Measure translation efficiency during plasticity |
| Proteomics | Protein abundance and modifications | Detect S-palmitoylation of synaptic proteins |
| Live imaging | Spine dynamics and synaptic structure | Visualize structural plasticity |
| Electrophysiology | Synaptic strength (LTP/LTD) | Assess functional plasticity |
| CRISPR screen | Gene function in plasticity | Discover novel regulators |
| Co-IP / mass spec | Protein-protein interactions | Map synaptic signaling complexes |
| ATAC-seq | Chromatin accessibility | Study epigenetic regulation |
Transcriptomic and translatomic profiling
RNA-seq and Ribo-seq can measure changes in gene expression and translation during synaptic plasticity. These methods help identify genes and pathways that are regulated in an activity-dependent manner. For example, alternative splicing events can be detected by RNA-seq, revealing isoforms critical for plasticity.
Proteomic and post-translational modification analysis
Proteomics, including palmitoylation proteomics, can identify synaptic proteins and their modifications that regulate plasticity. Mass spectrometry-based approaches allow quantification of S-palmitoylation dynamics on synaptic proteins.
Imaging and electrophysiology
Live-cell imaging of dendritic spines and synaptic markers, combined with electrophysiology, provides functional readouts of plasticity. These techniques can assess structural remodeling and changes in synaptic strength. Astrocyte and microglia interactions can be visualized using advanced microscopy.
CRISPR-based perturbation and screening
CRISPR knockout, point mutation, knock-in, and overexpression enable causal testing of candidate genes in plasticity regulation. Pooled CRISPR screens can identify novel regulators of synaptic plasticity in an unbiased manner.
How CRISPR Can Be Used to Study GO:0048168 regulation of neuronal synaptic plasticity
Knockout
CRISPR knockout is used to completely abolish the expression of a candidate gene to test its necessity for synaptic plasticity. For example, knocking out RGS14 or SHANK3 in neurons can reveal their roles in spine plasticity and synaptic function. Knockout models are also valuable for validating hits from CRISPR screens.
Point Mutation
CRISPR point mutation allows the introduction of specific disease-associated variants into endogenous genes. This is critical for modeling how single amino acid changes in proteins like GRIN2B or MAPT affect synaptic plasticity. Point mutation models provide insights into genotype-phenotype relationships.
Knock-in
Knock-in of reporter tags (e.g., fluorescent proteins) or epitope tags enables visualization and biochemical isolation of endogenous proteins. Tagging synaptic proteins like PSD-95 or AMPA receptor subunits allows tracking of their localization and dynamics during plasticity.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase the levels of a gene of interest to test sufficiency in promoting plasticity. Overexpressing BDNF or CAMK2A can enhance synaptic strength and plasticity. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports regulation of neuronal synaptic plasticity Research
Researchers studying regulation of neuronal synaptic plasticity-related genes often need to determine whether a candidate gene is causally involved in synaptic changes or merely correlated with them. This requires precise genetic manipulation, which can be achieved through CRISPR-based genome editing. EDITGENE provides a comprehensive suite of services to support such research, from knockout and point mutation to knock-in and overexpression, as well as library screening and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for regulation of neuronal synaptic plasticity research.
Frequently Asked Questions About regulation of neuronal synaptic plasticity
What is GO:0048168 regulation of neuronal synaptic plasticity?
GO:0048168 is a Gene Ontology biological process term that describes the modulation of neuronal synaptic plasticity, the ability of synapses to change their strength, number, or function in response to experience.
What genes are involved in regulation of neuronal synaptic plasticity?
Key genes include RGS14, ARC, BDNF, GRIA1, GABRA1, DLG4, SNAP25, GRIN2B, CAMK2A, MAPT, APOE, FMR1, MECP2, SHANK3, GRM5, ATP6V1A, and NEFL.
How is synaptic plasticity regulated at the molecular level?
It is regulated by post-translational modifications like S-palmitoylation, alternative splicing, epigenetic mechanisms, and signaling pathways involving RGS14 and CAMK2A.
What role do astrocytes play in synaptic plasticity?
Astrocytes instruct hippocampal synaptic plasticity through neuronal activity-dependent regulatory mechanisms and structural remodeling.
How do microglia regulate synaptic plasticity?
Microglia regulate neuronal activity via structural remodeling of astrocytes, which in turn influences synaptic plasticity.
What diseases are associated with dysregulated synaptic plasticity?
Neurodevelopmental disorders, neurodegenerative diseases like Alzheimer's, and psychiatric conditions such as schizophrenia and depression.
What methods are used to study regulation of neuronal synaptic plasticity?
Methods include RNA-seq, Ribo-seq, proteomics, live imaging, electrophysiology, and CRISPR screens.
How can CRISPR be used to study synaptic plasticity genes?
CRISPR knockout, point mutation, knock-in, and overexpression allow causal testing of gene function in plasticity.
What is the role of S-palmitoylation in synaptic plasticity?
S-Palmitoylation dynamically regulates the localization and function of synaptic proteins, influencing plasticity in normal and pathological brains.
Why is inhibitory synaptic plasticity important?
Inhibitory synaptic plasticity is crucial for shaping circuit organization and function and for maintaining excitation-inhibition balance.
Conclusion
Regulation of neuronal synaptic plasticity (GO:0048168) is a central biological process that enables the nervous system to adapt to experience. It involves complex interactions between neurons, glia, and molecular regulators such as RGS14, BDNF, and CAMK2A, and is dysregulated in numerous neurological and psychiatric disorders. Advances in CRISPR-based models and high-throughput methods are accelerating the discovery of causal mechanisms. EDITGENE offers a comprehensive toolkit to support researchers in dissecting these pathways, from gene knockout to library screening, ultimately aiding the development of targeted therapies.
References
- 1. Gu N et al.. 2025. Microglia regulate neuronal activity via structural remodeling of astrocytes.. Neuron 113(20):3408-3423.e5 PMID: 40834861
- 2. Bai I et al.. 2024. Epigenetic regulation of autophagy in neuroinflammation and synaptic plasticity.. Front Immunol 15:1322842 PMID: 38455054
- 3. Wu YK et al.. 2022. Regulation of circuit organization and function through inhibitory synaptic plasticity.. Trends Neurosci 45(12):884-898 PMID: 36404455
- 4. Buszka A et al.. 2023. S-Palmitoylation of Synaptic Proteins in Neuronal Plasticity in Normal and Pathological Brains.. Cells 12(3) PMID: 36766729
- 5. Harbin NH et al.. 2021. RGS14 Regulation of Post-Synaptic Signaling and Spine Plasticity in Brain.. Int J Mol Sci 22(13) PMID: 34201943
- 6. Wang Y et al.. 2022. Instructive roles of astrocytes in hippocampal synaptic plasticity: neuronal activity-dependent regulatory mechanisms.. FEBS J 289(8):2202-2218 PMID: 33864430
- 7. Ravasenga T et al.. 2022. Spatial regulation of coordinated excitatory and inhibitory synaptic plasticity at dendritic synapses.. Cell Rep 38(6):110347 PMID: 35139381
- 8. Furlanis E et al.. 2018. Regulation of Neuronal Differentiation, Function, and Plasticity by Alternative Splicing.. Annu Rev Cell Dev Biol 34:451-469 PMID: 30028642
